IBM (NYSE:IBM) has been given a consensus recommendation of “Hold” by the twenty-one analysts that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $156.41.
A number of analysts have commented on IBM shares. ValuEngine cut shares of IBM from a “hold” rating to a “sell” rating in a report on Thursday, April 18th. UBS Group set a $160.00 target price on shares of IBM and gave the company a “buy” rating in a report on Wednesday, April 17th. Zacks Investment Research raised shares of IBM from a “sell” rating to a “hold” rating in a report on Monday, April 22nd. Evercore ISI started coverage on shares of IBM in a report on Wednesday, June 5th. They set an “outperform” rating and a $150.00 target price for the company. Finally, Credit Suisse Group started coverage on shares of IBM in a report on Thursday, April 11th. They set an “outperform” rating and a $173.00 target price for the company.
IBM stock traded down $0.62 during midday trading on Monday, reaching $137.90. 6,153,948 shares of the company traded hands, compared to its average volume of 2,936,415. The stock has a market cap of $122.82 billion, a price-to-earnings ratio of 9.99, a price-to-earnings-growth ratio of 2.52 and a beta of 1.24. The company’s 50 day simple moving average is $134.29. IBM has a 12 month low of $105.94 and a 12 month high of $154.36. The company has a debt-to-equity ratio of 2.39, a current ratio of 1.36 and a quick ratio of 1.31.
IBM (NYSE:IBM) last issued its quarterly earnings data on Tuesday, April 16th. The technology company reported $2.25 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.22 by $0.03. The company had revenue of $18.18 billion for the quarter, compared to the consensus estimate of $18.53 billion. IBM had a net margin of 10.98% and a return on equity of 68.76%. The firm’s revenue for the quarter was down 4.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.45 earnings per share. Sell-side analysts forecast that IBM will post 13.89 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Monday, June 10th. Shareholders of record on Friday, May 10th were issued a dividend of $1.62 per share. This is a boost from IBM’s previous quarterly dividend of $1.57. This represents a $6.48 dividend on an annualized basis and a yield of 4.70%. The ex-dividend date was Thursday, May 9th. IBM’s dividend payout ratio is currently 46.92%.
In other news, SVP Kenneth M. Keverian sold 2,083 shares of the stock in a transaction on Tuesday, June 4th. The shares were sold at an average price of $132.00, for a total value of $274,956.00. Following the completion of the sale, the senior vice president now directly owns 34,465 shares of the company’s stock, valued at $4,549,380. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Kenneth M. Keverian sold 2,227 shares of the stock in a transaction on Friday, June 14th. The stock was sold at an average price of $135.15, for a total transaction of $300,979.05. Following the completion of the sale, the senior vice president now directly owns 32,878 shares of the company’s stock, valued at $4,443,461.70. The disclosure for this sale can be found here. Over the last three months, insiders sold 7,000 shares of company stock valued at $940,430. Corporate insiders own 0.19% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in IBM. Nalls Sherbakoff Group LLC purchased a new stake in shares of IBM in the fourth quarter worth $34,000. Sycomore Asset Management purchased a new stake in shares of IBM in the fourth quarter worth $81,000. Adell Harriman & Carpenter Inc. purchased a new stake in shares of IBM in the first quarter worth $207,000. Peoples Bank OH purchased a new position in IBM during the first quarter valued at $226,000. Finally, Wealthcare Advisory Partners LLC grew its stake in IBM by 16.0% during the first quarter. Wealthcare Advisory Partners LLC now owns 1,977 shares of the technology company’s stock valued at $279,000 after acquiring an additional 273 shares in the last quarter. 55.16% of the stock is owned by hedge funds and other institutional investors.
IBM Company Profile
International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers a portfolio of enterprise artificial intelligence platforms, such as analytics and data management platforms, cloud data services, talent management, and industry solutions primarily under the Watson Platform, Watson Health, and Watson Internet of Things names.
Recommended Story: Total Return
Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.